法规动态

FDA、EMA、TGA 及全球法规动态

#sumatriptan ×

2026年9月22日•1 分钟阅读

FDA Approves Mylan Sumatriptan Succinate Tablets (ANDA 077744)

The FDA has approved Mylan Pharmaceuticals' sumatriptan succinate tablets (25 mg, 50 mg, 100 mg) under ANDA 077744, with multiple labeling submissions recorded.